Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19

COVID-19 has been the talk of the year 2020, taking many lives and leaving others in critical conditions. It has clearly and severally been reported that the SARSCoV-2 uses the Angiotensin Converting Enzyme-2 receptors to penetrate and infect cells. Reports have also stated that the nasal and olfact...

Descripción completa

Detalles Bibliográficos
Autores principales: Vofo, Gaelle, Brodie, Ronit, Gross, Menachem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Letter to Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444481/
https://www.ncbi.nlm.nih.gov/pubmed/33254514
http://dx.doi.org/10.1016/j.mehy.2020.110207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444481/
https://www.ncbi.nlm.nih.gov/pubmed/33254514
http://dx.doi.org/10.1016/j.mehy.2020.110207

Ejemplares similares